“Trend Management”

40 result(s)
Drug Pipeline
New drugs to treat migraine are approaching approval and could bring relief for many patients, but they portend higher costs. Ongoing monitoring and appropriate utilization... More
Feature
Care Management
Payors can better manage oncology costs by optimizing therapy regimen selection using evidence-based guidelines directly integrated into our proprietary Novologix platform. More
Video
Cost Management
Payors are projected to save on per-member-per-month costs from strategic formulary removals designed to help mitigate the effect of high-cost and hyperinflationary drugs More
Briefing
Specialty
CVS Health uses its integrated model to manage specialty spend across benefits and help positively impact clinical and financial outcomes. More
Briefing
Public Policy
Our perspective offered to Congress on solutions and policies that can help bring escalating drug prices under control. More
Commentary
Young man feeding his dog in the living room
Cost Management
Epidiolex, the latest cannabis-based drug to be approved by the FDA to treat certain seizure disorders, is a highly potent form of cannabidiol. Given the narrow indication and... More
Feature
Elderly lady eating cherries
Cost Management
New CMS rule enables Medicare Part B Payors to use step therapy to direct patients to lower-cost, clinically appropriate medications first, giving them an opportunity to implement... More
Briefing
Male patient holding a pill bottle and glass of water
Cost Management
CVS Caremark’s QALY-based program aims to bring rationality to drug pricing using comparative effectiveness research and cost-effectiveness analysis, and get manufacturers to set... More
Commentary
Cover image of the Whitepaper PDF document
Cost Management
CVS Health is proposing innovations that build on existing PBM techniques to help patients afford the medications they need and improving outcomes while lowering high drug maker... More
White Paper
Senior couple walking on a beach
Specialty
CVS Health’s three-tier specialty formulary design separates the increasingly more expensive specialty therapies into three distinct copay or coinsurance categories. Paired with... More
Briefing